Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany.
Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany.
复制标题
DOI：
10.1007/s00404-020-05880-0
复制
发表时间：
2021-05
影响因子：
2.6
通讯作者：
Paepke D
中科院分区：
文献类型：
--
作者：
Grimm D;Mathes S;Woelber L;Van Aken C;Schmalfeldt B;Mueller V;Kiechle M;Brambs C;Paepke D
这项多中心横断面研究的目的是分析一组乳腺癌 (BC) 和妇科癌症 (GC) 患者对综合治疗健康方法的兴趣、看法和需求。 BC 和 GC 患者在第一次综合诊所就诊时使用经过验证的标准化问卷进行了调查。评估了两组之间的治疗目标和潜在差异。 340 名患者（272 名 BC，68 名 GC）参与了该研究。对 IM 的总体兴趣为 95.3%，并且与年龄较大、近期化疗和高等教育相关。共有 89.4% 的人在入组时使用综合方法，主要是运动疗法（57.5%）和补充维生素（51.4%）。 BC 患者的主要短期目标是减少常规治疗的副作用（70.4%）；主要的长期目标是延迟潜在的肿瘤进展（69.3%）。在GC组中，主要的短期和长期目标是减缓肿瘤进展（73.1%和79.1%）和延长生存期（70.1%和80.6%）。与 BC 患者相比，GC 患者受到常规治疗副作用的影响明显更大[疼痛 (p = 0.006)、便秘 (< 0.005)]。我们的数据表明 BC 和 GC 患者对 IM 的整体兴趣和使用很高。这支持了对两个患者组进行专门的 IM 咨询和在传统肿瘤治疗方案中实施综合治疗的需要。原发肿瘤部位、癌症诊断、治疗阶段和副作用对我们的研究人群对 IM 的需求有相关影响。
The aim of this multicenter cross-sectional study was to analyze a cohort of breast (BC) and gynecological cancer (GC) patients regarding their interest in, perception of and demand for integrative therapeutic health approaches. BC and GC patients were surveyed at their first integrative clinic visit using validated standardized questionnaires. Treatment goals and potential differences between the two groups were evaluated. 340 patients (272 BC, 68 GC) participated in the study. The overall interest in IM was 95.3% and correlated with older age, recent chemotherapy, and higher education. A total of 89.4% were using integrative methods at the time of enrolment, primarily exercise therapy (57.5%), and vitamin supplementation (51.4%). The major short-term goal of the BC patients was a side-effects reduction of conventional therapy (70.4%); the major long-term goal was the delay of a potential tumor progression (69.3%). In the GC group, major short-term and long-term goals were slowing tumor progression (73.1% and 79.1%) and prolonging survival (70.1% and 80.6%). GC patients were significantly more impaired by the side-effects of conventional treatment than BC patients [pain (p = 0.006), obstipation (< 0.005)]. Our data demonstrate a high overall interest in and use of IM in BC and GC patients. This supports the need for specialized IM counseling and the implementation of integrative treatments into conventional oncological treatment regimes in both patient groups. Primary tumor site, cancer diagnosis, treatment phase, and side effects had a relevant impact on the demand for IM in our study population.
登录
查看更多内容
影响因子：
3.1
作者：
Fasching, P. A.;Thiel, F.;Bani, M. R.
通讯作者：
Bani, M. R.
影响因子：
--
作者：
ERNST, E;RESCH, KL;WHITE, AR
通讯作者：
WHITE, AR
影响因子：
2.7
作者：
Hack, C. C.;Huettner, N. B. M.;Beckmann, M. W.
通讯作者：
Beckmann, M. W.
DOI：
10.1097/igc.0000000000000867
发表时间：
2017-02-01
影响因子：
4.8
作者：
Bronger, Holger;Hederich, Philipp;Schmalfeldt, Barbara
通讯作者：
Schmalfeldt, Barbara
影响因子：
158.5
作者：
Burstein, HJ;Gelber, S;Weeks, JC
通讯作者：
Weeks, JC